Fund Holdings — Foresite Capital Management V, LLC

Total Portfolio Value:
$289.15M
Total Bought:
$67.55M
Total Sold:
$6.69M
Net Transaction:
+$60.86M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.(CGON)1,079,0501,079,0500$76.67M$76.49M26.45%-$172.6K
Latigo Biotherapeutics, Inc.03,562,984+3,562,984$0$59.50M20.58%+$59.50M
Alumis Inc.5,896,9955,896,9950$165.94M$43.58M15.07%-$122.36M
Hims & Hers Health, Inc.CL A(HIMS)738,151883,751+145,600$25.59M$26.33M9.11%+$735.2K
Disc Medicine, Inc.(IRON)374,069374,0690$27.36M$24.49M8.47%-$2.87M
Pharvaris N.V.
COM
664,142664,1420$22.97M$21.07M7.29%-$1.90M
Odyssey Therapeutics, Inc.713,105729,602+16,497$13.34M$16.21M5.61%+$2.87M
Nurix Therapeutics, Inc.(NRIX)265,000458,742+193,742$6.43M$10.88M3.76%+$4.45M
Eikon Therapeutics, Inc.(EIKN)1,318,9831,318,9830$17.21M$10.60M3.67%-$6.61M
Lyell Immunopharma, Inc.(LYEL)476,3860-476,386$6.69M$0—-$6.69M
Page 1 of 1
Foresite Capital Management V, LLC — 13F Holdings — Q3 2026 | TickerTrail